Qualitative comparison of the results of the ISS T-002 and the ISS OBS T-002 up to 48 weeks: central and effector memory T cell phenotype and cellular immune responses.

aSubjects enrolled in the clinical trial; bsubjects enrolled in the OBS study with the same characteristics at baseline of the trial patients; c all evaluable subjects enrolled in the OBS study. +, increase; −, decrease; +/−, fluctuations (higher and lower levels as compared to baseline at different time points);  =  stable; (∗), statistically significant in at least one time point.